Trial Profile
Open, Non-Interventional, Multicentre Trial of Rituximab in Combination With FC for the First-Line Therapy of Patients With Chronic Lymphocytic Leukaemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- Sponsors Roche
- 05 Jun 2015 New trial record